Skip to main content

Jemperli

NDC 0173-0898 · GlaxoSmithKline LLC

Generic namedostarlimab
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)DOSTARLIMAB
Strength50 mg/mL
Pharmacologic classProgrammed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Marketing categoryBLA

Packages

0173-0898-03 — 1 VIAL in 1 CARTON (0173-0898-03) / 10 mL in 1 VIAL

Billed under HCPCS

J9272 — Injection, dostarlimab-gxly, 10 mg Medicare Part B payment limit (ASP + 6%): $251.30

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.